Quick Answer
Jazz Pharmaceuticals plc reported Shares Outstanding of 61.44 million shares for fiscal year 2025.
Jazz Pharmaceuticals plc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 61.44M | +1.3% |
| 2024 | 60.63M | -2.6% |
| 2023 | 62.26M | -1.5% |
| 2022 | 63.21M | +2.6% |
| 2021 | 61.63M | +9.7% |
| 2020 | 56.17M | +0.1% |
| 2019 | 56.14M | -2.7% |
| 2018 | 57.70M | -2.0% |
| 2017 | 58.90M | -1.5% |
| 2016 | 59.82M | -2.4% |
| 2015 | 61.30M | +1.1% |
| 2014 | 60.64M | +4.8% |
| 2013 | 57.85M | -0.3% |
| 2012 | 58.01M | +36.6% |
| 2011 | 42.47M | +6.3% |
| 2010 | 39.96M | — |
- Jazz Pharmaceuticals plc showed an increase of +1.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Jazz Pharmaceuticals plc’s shares outstanding has grown by 53.7% (from 39.96 million shares to 61.44 million shares).
- The most recent figure is from Jazz Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: